English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Summary  The effects of epinephrine-induced dysrhythmias were evaluated in sixteen 15-20 kg mongrel dogs anaesthetized with halogenated inhalation agents, nitrous oxide and pancuronium and with narcotics, nitrous oxide and pancuronium. Group I consisted of eight animals which received 1.2 MAC halothane, enflurane or methoxyflurane in nitrous oxide and oxygen (2.5/2.5 litres) and Group 2 of eight animals which received morphine (1 and 2 mg·kg-1), fentanyl (0.01 and 0.02 mg·kg-1) and meperidine (10 and 20 mg·kg-1) with nitrous oxide and oxygen (2.5/2.5 litres). Pancuronium (0.2 mg·kg-1) was administered to both groups. Each animal in Group 1 or 2 was studied three times but only once a week and one anaesthetic regimen per study. The order of administration of the anaesthetic regimen was randomized for both groups.  Lead II of the electrocardiogram, oesophageal temperature and arterial pressure were monitored continuously. Arterial blood gases and serum sodium and potassium were determined during control, during the peak pressure response from epinephrine infusion and every 30 minutes for the rest of the study. Epinephrine (5 μg/ml) was infused at a rate of 1 μgkg-1μmin-1 up to ten minutes. The persistence of three or more consecutive dysrhythmic beats was used as the end-point of the epinephrine arrhythmogenic dose. Arterial blood gases showed minimal changes in both groups during the course of the experiment with$$Pa_{O_2 } $$ 24 ± 2.13 kPa ( 180 ± 16 torr),$$Pa_{CO_2 } $$ 4.8 ± 0.4 kPa (36 ± 3 torr) and cH+ 43.65 ± 0.14 nmol/l (pH 7.36 ± 0.07). Serum sodium did not change significantly during the experiment, but serum potassium increased to a peak concentration of 6.5 ± 0.4 mmol/l during the epinephrine infusion. The ventricular dysrhythmic dose of epinephrine was generally higher than the corresponding supraventricular dysrhythmic dose for each anaesthetic regimen for both groups. The arrhythmogenic doses for the halogenated-nitrous oxide anaesthesia groups were significantly higher thanfor the narcoticnitrous oxide groups; however, the incidence of ventricular arrhythmias was greater in the halo-genated-nitrous oxide groups (20 of 24 vs 20 of 48). The incidence of ventricular arrhythmias was less in the methoxyflurane-nitrous oxide group (4/8) than in the halothane-nitrous oxide (8/8) or enflurane-nitrous oxide (8/8) groups. Ventricular tachycardia and ventricular fibrillation occurred in five of eight in the halothane group, three of eight in the enflurane group and in none of the eight in the methoxyflurane group, compared with an occurrence of one out of 48 epinephrine challenges in the narcotic-nitrous oxide groups. These results suggest that anaesthesia with narcotics or methoxyflurane with nitrous oxide and relaxants may stabilize the heart against serious epinephrine-induced ventricular dysrhythmias better than anaesthesia with halogenated inhalation agents, nitrous oxide and relaxant.

Epinephrine-induced dysrhythmias: comparison during anaesthesia with narcotics and with halogenated inhalation agents in dogs